PureTech Health (PRTC) Leases (2023 - 2025)

PureTech Health (PRTC) reported Leases of $7.2 million for Q2 2025, down 10.94% on a QoQ basis from $8.1 million in Q4 2024.

PureTech Health (PRTC) has 3 years of Leases data on file, last reported at $7.2 million in Q2 2025.

  • Quarterly Leases changed N/A year-over-year to $7.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $7.2 million (changed N/A YoY) and the FY2024 annual result came in at $8.1 million, up 182.05% from the prior year.
  • Leases fell to $7.2 million in Q2 2025 per PRTC's latest filing, from $8.1 million in the prior quarter.
  • Across five years, Leases topped out at $8.1 million in Q4 2024 and bottomed at -$9.8 million in Q4 2023.
  • The 3-year median for Leases is $7.2 million (2025), against an average of $1.8 million.
  • Peak annual rise in Leases reached 182.05% in 2024, while the deepest fall reached 182.05% in 2024.
  • Tracing PRTC's Leases over 3 years: stood at -$9.8 million in 2023, then jumped by 182.05% to $8.1 million in 2024, then declined by 10.94% to $7.2 million in 2025.
  • Per Business Quant, the three latest PRTC Leases figures stand at $7.2 million (Q2 2025), $8.1 million (Q4 2024), and -$9.8 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 83,048.00
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 61,822.50
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 1.69 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 189.30 Mn
10 PureTech Health 86.36 Mn -190.94 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 7.18 Mn
Dec 31, 2024 8.06 Mn
Dec 31, 2023 -9.83 Mn